U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547995) titled 'A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.' on April 14.
Brief Summary: This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.
Study Start Date: June 18
Study Type: INTERVENTIONAL
Condition:
Uveitis
Intervention:
DRUG: GenSci048 High-dose
High-dose Administered SC.
DRUG: GenSci048 Low-dose
Low-dose Administered SC.
DRUG: Placebo
Administered SC.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from...